SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-040735
Filing Date
2017-02-13
Accepted
2017-02-13 17:07:56
Documents
9
Period of Report
2017-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d297669d8k.htm 8-K 17491
2 EX-1.1 d297669dex11.htm EX-1.1 185196
3 EX-5.1 d297669dex51.htm EX-5.1 15072
4 EX-99.1 d297669dex991.htm EX-99.1 8132
5 EX-99.2 d297669dex992.htm EX-99.2 8186
6 GRAPHIC g297669001.jpg GRAPHIC 2960
7 GRAPHIC g297669002.jpg GRAPHIC 1917
8 GRAPHIC g297669g0210101833283.jpg GRAPHIC 3564
9 GRAPHIC g297669g0210102222896.jpg GRAPHIC 3564
  Complete submission text file 0001193125-17-040735.txt   252552
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 17600497
SIC: 2836 Biological Products, (No Diagnostic Substances)